Biological properties of dehydrated human amnion/chorion composite graft: implications for chronic wound healing.
Thomas J. Koob,Robert C. Rennert,Nicole Zabek,Michelle Massee,Jeremy J. Lim,Johnna S. Temenoff,William W. Li,Geoffrey C. Gurtner +7 more
TLDR
PURION® processed dHACM retains its biological activities related to wound healing, including the potential to positively affect four distinct and pivotal physiological processes intimately involved in wound healing: cell proliferation, inflammation, metalloproteinase activity and recruitment of progenitor cells.Abstract:
Human amnion/chorion tissue derived from the placenta is rich in cytokines and growth factors known to promote wound healing; however, preservation of the biological activities of therapeutic allografts during processing remains a challenge. In this study, PURION® (MiMedx, Marietta, GA) processed dehydrated human amnion/chorion tissue allografts (dHACM, EpiFix®, MiMedx) were evaluated for the presence of growth factors, interleukins (ILs) and tissue inhibitors of metalloproteinases (TIMPs). Enzyme-linked immunosorbent assays (ELISA) were performed on samples of dHACM and showed quantifiable levels of the following growth factors: platelet-derived growth factor-AA (PDGF-AA), PDGF-BB, transforming growth factor α (TGFα), TGFβ1, basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), placental growth factor (PLGF) and granulocyte colony-stimulating factor (GCSF). The ELISA assays also confirmed the presence of IL-4, 6, 8 and 10, and TIMP 1, 2 and 4. Moreover, the relative elution of growth factors into saline from the allograft ranged from 4% to 62%, indicating that there are bound and unbound fractions of these compounds within the allograft. dHACM retained biological activities that cause human dermal fibroblast proliferation and migration of human mesenchymal stem cells (MSCs) in vitro. An in vivo mouse model showed that dHACM when tested in a skin flap model caused mesenchymal progenitor cell recruitment to the site of implantation. The results from both the in vitro and in vivo experiments clearly established that dHACM contains one or more soluble factors capable of stimulating MSC migration and recruitment. In summary, PURION® processed dHACM retains its biological activities related to wound healing, including the potential to positively affect four distinct and pivotal physiological processes intimately involved in wound healing: cell proliferation, inflammation, metalloproteinase activity and recruitment of progenitor cells. This suggests a paracrine mechanism of action for dHACM when used for wound healing applications.read more
Citations
More filters
Journal ArticleDOI
Challenges in the Treatment of Chronic Wounds.
TL;DR: The pathophysiology of complex chronic wounds and the means and modalities currently available to achieve healing in such patients are discussed, with a focus on diabetic foot ulcers.
Journal ArticleDOI
Wound Healing: A Cellular Perspective.
TL;DR: It is shown that changes in the microenvironment including alterations in mechanical forces, oxygen levels, chemokines, extracellular matrix and growth factor synthesis directly impact cellular recruitment and activation, leading to impaired states of wound healing.
Journal ArticleDOI
Wound Dressings and Comparative Effectiveness Data.
TL;DR: The point of using advanced dressings is to improve upon specific wound characteristics to bring it as close to "ideal" as possible, and it is only after properly assessing the wound characteristics and obtaining knowledge about available products that the "ideals" dressing may be chosen.
Journal ArticleDOI
Wound healing and treating wounds: Chronic wound care and management
TL;DR: In this article, recent advances in wound care technology and current management guidelines for the treatment of wounds and ulcers are discussed.
Journal ArticleDOI
Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets.
TL;DR: The pathophysiology of both acute and chronic wounds and possible strategies to control the immune system to accelerate chronic wound closure and promote skin regeneration (scar-less healing) of acute wounds are discussed.
References
More filters
Journal ArticleDOI
An Analysis of Transformations
George E. P. Box,David Cox +1 more
TL;DR: In this article, Lindley et al. make the less restrictive assumption that such a normal, homoscedastic, linear model is appropriate after some suitable transformation has been applied to the y's.
Journal ArticleDOI
Growth factors and cytokines in wound healing.
TL;DR: A review of the specific roles of these growth factors and cytokines during wound healing can be found in this article, where patients are treated by three growth factors: PDGF-BB, bFGF, and GM-CSF.
Journal ArticleDOI
Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis.
TL;DR: The data suggest that bone marrow‐derived mesenchymal stem cells promote wound healing through differentiation and release of proangiogenic factors.
Journal ArticleDOI
Clinical application of growth factors and cytokines in wound healing.
TL;DR: Four growth factors and cytokines currently being used on and off label for the healing of wounds are discussed, including granulocyte‐macrophage colony‐stimulating factor, platelet‐derived growth factor, vascular endothelial growth factors, and basic fibroblast growth factor.
Journal ArticleDOI
Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers
TL;DR: Once-daily topical application of rhPDGF-BB is safe and effective in stimulating the healing of chronic, full-thickness, lower-extremity diabetic neurotrophic ulcers.